Literature DB >> 21842535

Notch signaling dependent differentiation of cholangiocyte-like cells from rhesus monkey embryonic stem cells.

Li-Fang Jin1, Shao-Hui Ji, Ji-Feng Yang, Wei-Zhi Ji.   

Abstract

Rhesus monkey embryonic stem (rES) cells have similar characteristics to human ES cells, and might be useful as a substitute model for preclinical research. Notch signaling is involved in the formation of bile ducts, which are composed of cholangiocytes. However, little is known about the role of Notch signaling in cholangiocytic commitment of ES cells. We analyzed the effect of Notch signaling on the induction of cholangiocyte-like cells from rES cells. About 80% of definitive endoderm (DE) cells were generated from rES cells after treatment with activin A. After treatment with BMP4 and FGF1 on matrigel coated wells in serum-free medium, rES-derived DE gave rise to cholangiocyte-like cells by expression of cholangiocytic specific proteins (CK7, CK18, CK19, CK20, and OV-6) and genes (GSTPi, IB4, and HNF1β). At the same time, expression of Notch 1 and Notch 2 mRNA were detected during cell differentiation, as well as their downstream target genes such as Hes 1 and Hes 5. Inhibition of the Notch signal pathway by L-685458 resulted in decreased expression of Notch and their downstream genes. In addition, the proportion of cholangiocyte-like cells declined from approximately 90% to approximately 20%. These results suggest that Notch signaling may play a critical role in cholangiocytic development from ES cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21842535     DOI: 10.3724/SP.J.1141.2011.04391

Source DB:  PubMed          Journal:  Dongwuxue Yanjiu        ISSN: 0254-5853


  3 in total

1.  Interference of Notch1 inhibits the growth of glioma cancer cells by inducing cell autophagy and down-regulation of Notch1-Hes-1 signaling pathway.

Authors:  Junchao Yao; Kebin Zheng; Chunhui Li; Haipeng Liu; Xiaosong Shan
Journal:  Med Oncol       Date:  2015-04-29       Impact factor: 3.064

Review 2.  Cellular therapy for liver disease.

Authors:  Robert C Huebert; Jorge Rakela
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

3.  Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes.

Authors:  Thiago M De Assuncao; Yan Sun; Nidhi Jalan-Sakrikar; Mary C Drinane; Bing Q Huang; Ying Li; Jaime I Davila; Ruisi Wang; Steven P O'Hara; Gwen A Lomberk; Raul A Urrutia; Yasuhiro Ikeda; Robert C Huebert
Journal:  Lab Invest       Date:  2015-04-13       Impact factor: 5.662

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.